Cargando…

Safety concerns with higher dosage chloroquine in COVID-19 patients

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197234/ http://dx.doi.org/10.1007/s40278-020-77929-x

Ejemplares similares

Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations
por: Karalis, Vangelis, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
por: Nicolò, Massimo, et al.
Publicado: (2020)

COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help
por: Lentini, Giovanni, et al.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Hydroxychloroquine/chloroquine and the risk of acute kidney injury in COVID-19 patients: a systematic review and meta-analysis
por: Liao, Zheng-Ming, et al.
Publicado: (2022)

Hydroxychloroquine- and chloroquine-related cardiovascular events
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

COVID-10 vaccine safety monitoring in US: no serious concerns
Publicado: (2021)

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
por: Kamp, Timothy J., et al.
Publicado: (2020)

Spectral-Domain Optical Coherence Tomography of Preclinical Chloroquine Maculopathy in Egyptian Rheumatoid Arthritis Patients
por: Allam, Riham S. H. M., et al.
Publicado: (2015)

Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon
por: Graf, Paul C. F., et al.
Publicado: (2012)

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)

Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19
por: Gao, Xiuge, et al.
Publicado: (2022)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
por: Biswas, Partha Sarathi, et al.
Publicado: (2020)

CAUTION WITH CHLOROQUINE: A CASE OF CHLOROQUINE CARDIOTOXICITY
por: Pelter, Megan, et al.
Publicado: (2023)

Higher P-Wave Dispersion in Migraine Patients with Higher Number of Attacks
por: Koçer, A., et al.
Publicado: (2012)

Cardiac risks higher after COVID-19 infection than mRNA vaccine
Publicado: (2022)

Study of Feasibility and Safety of Higher-Dose Dexmedetomidine in Special Outpatient Examination of Pediatric Ophthalmology
por: Chen, Chaoqiao, et al.
Publicado: (2019)

Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy
por: Linden-Castro, Edgar, et al.
Publicado: (2014)

Response to correspondence concerning: “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
por: Lammers, A.J.J., et al.
Publicado: (2021)

Of chloroquine and COVID-19
por: Touret, Franck, et al.
Publicado: (2020)

Estimated direct costs of COVID-19 pandemic high in Turkey, but true costs "undoubtedly higher"
Publicado: (2021)

Dosage Optimization for Letrozole Treatment in Clomiphene-Resistant Patients with Polycystic Ovary Syndrome: A Prospective Interventional Study
por: Rahmani, Elham, et al.
Publicado: (2012)

Relationship between selection of dosage forms of vitamin D receptor activators and short-term survival of patients on hemodialysis
por: Koshi-Ito, Eri, et al.
Publicado: (2021)

Safety of seven COVID-19 vaccine booster doses
Publicado: (2021)

Prospective Randomized Study for Antibiotic Prophylaxis in Spine Surgery: Choice of Drug, Dosage, and Timing
por: Nishant,, et al.
Publicado: (2013)

Brief Report: Retrospective Evaluation on the Efficacy of Lopinavir/Ritonavir and Chloroquine to Treat Nonsevere COVID-19 Patients
por: Gao, Guiju, et al.
Publicado: (2020)

Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19
por: Guzman-Prado, Yuli
Publicado: (2020)

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
por: Cortegiani, Andrea, et al.
Publicado: (2020)

Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson's Disease
por: Yun, Ji Young, et al.
Publicado: (2017)

Pfizer COVID-19-related drug use and safety surveillance
Publicado: (2021)

Safety of mRNA COVID-19 vaccines during pregnancy
Publicado: (2022)

Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients
por: Yao, Xueting, et al.
Publicado: (2020)

Bioartificial Therapy of Sepsis: Changes of Norepinephrine-Dosage in Patients and Influence on Dynamic and Cell Based Liver Tests during Extracorporeal Treatments
por: Sauer, Martin, et al.
Publicado: (2016)

Chloroquine for COVID-19 Infection
por: Moore, Nicholas
Publicado: (2020)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_72918c79o7otkpemhbqdcjjkep